1-8 of 8
Michal Karas
Close
Sort by
Journal Articles

Real World Population- Based Data from Nationwide Registry Support the Existence of Accelerated Phase in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients Even in Tyrosine Kinase Inhibitors (TKIs) Era

Tomas Hornak, Jiri Mayer, Petra Cicatkova, Lukas Semerad, Anezka Kvetkova, Hana Klamova, Edgar Faber, Petra Belohlavkova, Michal Karas, Lukas Stejskal, Eduard Cmunt, Olga Cerna, Dana Srbova, Hana Zizkova, Lucia Vrablova, Ivana Skoumalova, Jaroslava Voglova, Tereza Jurkova, Marika Chrapava, Tomas Jurcek, Ivana Jeziskova, Marie Jarosova, Katerina Machova Polakova, Tomas Papajik, Pavel Zak, Pavel Jindra, Daniela Zackova
Journal: Blood
Blood (2023) 142 (Supplement 1): 3166.
https://doi.org/10.1182/blood-2023-174455
Published: 2023
Journal Articles

Half: A Prospective Multi-Centre Phase II Clinical Trial Evaluating the Efficacy and Safety of Tyrosine Kinase Inhibitors' Discontinuation after Two-Step Dose Reduction in Patients with Chronic Myeloid Leukemia in Deep Molecular Remission

Daniela Žácková, Edgar Faber, Lukáš Stejskal, Michal Karas, Petra Bělohlávková, Hana Klamová, Olga Černá, Eduard Cmunt, Petra Čičátková, Lukáš Semerád, Tomáš Horňák, Anežka Kvetková, Jiřina Procházková, Jitka Rychlíčková, Radka Štěpánová, Adam Svobodník, Kateřina Machová Poláková, Ivana Ježíšková, Tomáš Jurček, Marek Borský, Ondřej Wiewiorka, Regina Demlová, Jiří Mayer
Journal: Blood
Blood (2021) 138 (Supplement 1): 3606.
https://doi.org/10.1182/blood-2021-146221
Published: 2021
Journal Articles

Center Characteristics and Procedure-Related Factors Have an Impact on Outcomes of Allogeneic Transplantation for Patients with CLL: A Retrospective Analysis from the European Society for Blood and Marrow Transplantation (EBMT)

Johannes Schetelig, MD MSc, Liesbeth C de Wreede, PhD, Niels S. Andersen, MD PhD, Carol Moreno, MD, Michel van Gelder, MD PhD, Antonin Vitek, MD PhD, Michal Karas, MD, Mauricette Michallet, MD PhD, Maciej J Machaczka, MD, Martin Gramatzki, MD, Dietrich W. Beelen, Prof. Dr. MD, Jurgen Finke, MD, Julio Delgado, Liisa Volin, MD PhD, Jakob Passweg, MD, Peter Dreger, MD, Nicolaas PM Schaap, MD PhD, Matthias Theobald, MD, Anja Henseler, Anja van Biezen, Martin Bornhaeuser, Simona Iacobella, Hein Putter, Prof. Dr, Stefen Schönland, Prof. Dr., Nicolaus Kröger, Prof. Dr
Journal: Blood
Blood (2016) 128 (22): 4663.
https://doi.org/10.1182/blood.V128.22.4663.4663
Published: 2016
Journal Articles

Allogeneic Hematopoietic Transplantation in Patients with CLL: Results of a Large Disease-Specific Risk Factor Analysis

Johannes Schetelig, MD M. Sc,, Liesbeth de Wreede, Michel van Gelder, Niels Smedegaard Andersen, Carol Moreno, Antonin Vitek, Michal Karas, MD, Mauricette Michallet, MD PhD, Maciej J Machaczka, Martin Gramatzki, Dietrich Beelen, MD, Jürgen Finke, MD, Álvaro Urbano-Ispizúa, Liisa Volin, MD PhD, Jakob R. Passweg, MD, Peter Dreger, MD, Anja Henseler, Anja van Biezen, Martin Bornhäuser, MD, Stefan Schoenland, MD, Nicolaus Kröger, MD
Journal: Blood
Blood (2015) 126 (23): 3209.
https://doi.org/10.1182/blood.V126.23.3209.3209
Published: 2015
Journal Articles

Long-Term Follow-up Data Support the Curative Potential of Allogeneic Hematopoietic Cell Transplantation in Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis from the Chronic Malignancies Working Party of the EBMT

Michel Van Gelder, MD, PhD, Liesbeth de Wreede, PhD, Anja Henseler, MSc, Anja van Biezen, Dietger Niederwieser, MD, Michal Karas, Niels S. Andersen, MD, Martin Gramatzki, MD, Peter Dreger, MD, Donald W. Bunjes, MD, Eefke J Petersen, MDPhD, Michael N Potter, MD PhD, Dietrich Beelen, MD, Ibrahim Yakoub-Agha, MD PhD, Jan J Cornelissen, MD PhD, Nigel Russell, Jurgen Finke, MD, Helene Schoemans, MD, Didier Blaise, MD, Paneesha Shankara, MD, Antonin Vitek, Martin Bornhäuser, MD, Stefan Schönland, Nicolaus Kröger, MD, Johannes Schetelig, MD M. Sc,
Journal: Blood
Blood (2014) 124 (21): 2561.
https://doi.org/10.1182/blood.V124.21.2561.2561
Published: 2014
Journal Articles

Five-Color Multiplex Real-Time PCR Technology to Detect Over 75 Recurrent Chromosomal Abnormalities in Acute Myeloid Leukemia; Benefits for Minimal Residual Disease Detection

Radek Plachy, Lenka Zejskova, Radek Cmejla, PhD, David Warren Hardekopf, Tereza Jancuskova, Lucie Krutilkova, Michal Karas, Vladimir Koza, MD, Jan Vydra, Pavel Zak, MD, PhD, Lukas Smolej, M.D., Ph.D., Sona Pekova
Journal: Blood
Blood (2011) 118 (21): 2526.
https://doi.org/10.1182/blood.V118.21.2526.2526
Published: 2011
Journal Articles

Identification of Novel Molecular Markers for the Follow-up of Minimal Residual Disease in Hematooncological Disorders

David Warren Hardekopf, Tereza Jancuskova, Marie Jarosova, Lucie Krutilkova, Radek Plachy, Lenka Zejskova, Radek Cmejla, PhD, Jan Vydra, Tomas Kozak, MD, PhD, Michal Karas, Vladimir Koza, MD, Alzbeta Zavrelova, MD, Pavel Zak, MD, PhD, Lukas Smolej, M.D., Ph.D., Sona Pekova
Journal: Blood
Blood (2011) 118 (21): 4905.
https://doi.org/10.1182/blood.V118.21.4905.4905
Published: 2011
Journal Articles

The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses – Population Based Analysis of 458 Patients Treated Between 2003–2009.

Hana Klamova, Daniela Zackova, Edgar Faber, MD, PhD, Katerina Steinerova, Michal Karas, Eva Demeckova, Jaroslava Voglova, MD, Ludmila Demitrovicova, Elena Tothova, Juraj Chudej, MD, Imrich Markuljak, Tomas Kozak, Eduard Cmunt, M.D., Ph.D., Marie Jarosova, Katerina Machova-Polakova, Kyra Michalova, PhD, DSc, Ladislav Dusek, Jan Muzik, Martin Mistrik, Jiri Mayer, MD, PhD, Marek Trneny, MD, PhD, Karel Indrak, MD., PhD.
Journal: Blood
Blood (2010) 116 (21): 1239.
https://doi.org/10.1182/blood.V116.21.1239.1239
Published: 2010